secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARLSMED, INC. (CARL)
CIK:        0001794546
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009828
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Carlsmed reports Q4 revenue ~$15.2M (+61% YoY); FY2025 ~$50.5M (+86% YoY)
-------------------------------------------------------------------------

- Preliminary Q4 2025 revenue of ~$15.2M, 61% increase over Q4 2024.
- Full-year 2025 revenue of ~$50.5M, 86% increase over 2024.
- Added 101 new surgeon users in 2025, a 61% increase in user base.
- Launched aprevo® cervical; early surgeon feedback encouraging.
- CEO cites transformational year; company focused on operational excellence for 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1794546/000119312526009828/0001193125-26-009828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1794546/000119312526009828/carl-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer